OOIR: Observatory of International Research

Papers

(The H4-Index of Vaccine is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?	792
Evidence for antibody as a protective correlate for COVID-19 vaccines	727
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic	469
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	460
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	381
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	355
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	344
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional surv	317
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	253
mRNA vaccines manufacturing: Challenges and bottlenecks	215
Human monkeypox – After 40 years, an unintended consequence of smallpox eradication	202
Myocarditis following COVID-19 mRNA vaccination	200
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	185
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	180
Vaccine hesitancy and perceived behavioral control: A meta-analysis	174
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	165
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	142
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	141
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data	140
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	136
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	135
Individual preferences for COVID-19 vaccination in China	134
The disease burden of influenza beyond respiratory illness	131
COVID-19 vaccine intentions in the United States, a social-ecological framework	128
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	118

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	117
Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US	115
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	114
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	113
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	113
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	112
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	109
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	107
The demand for a COVID-19 vaccine in Ecuador	105
Towards a population-based threshold of protection for COVID-19 vaccines	104
Arboviruses: A global public health threat	104
Contingent assessment of the COVID-19 vaccine	102
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	100
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	100
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	100
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines	97
Timing of COVID-19 vaccine approval and endorsement by public figures	95
Preferences for a COVID-19 vaccine in Australia	95
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	94
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	84
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	84
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	84
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	83
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	82
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	81
Christian nationalism and COVID-19 vaccine hesitancy and uptake	77
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	76
COVID-19 vaccine – Long term immune decline and breakthrough infections	76
Influenza immunization and COVID-19	74
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	74
Vaccination against coronaviruses in domestic animals	74
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	72
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	72
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	72
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	69
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	69
The need for inclusion of pregnant women in COVID-19 vaccine trials	68
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	66
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey	65
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	65